Screener
Taysha Gene Therapies, Inc. TSHA Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Taysha Gene Therapies, Inc.’s reported figures.
The source filing: Taysha Gene Therapies, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344610
FAQ
- What is Taysha Gene Therapies, Inc.'s invested capital?
- Taysha Gene Therapies, Inc. (TSHA) reported invested capital of -$11.43M in Q2 2026.
- How has Taysha Gene Therapies, Inc.'s invested capital changed year-over-year?
- Taysha Gene Therapies, Inc.'s invested capital decreased by 167.6% year-over-year, from -$4.27M to -$11.43M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s invested capital?
- Over 4 years (2021 to 2025), Taysha Gene Therapies, Inc.'s invested capital has grown at a -36.5% compound annual growth rate (CAGR), from -$16.53M to -$2.69M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Taysha Gene Therapies, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude